Lucas, Anika, Christina M. Wyatt, and Lesley A. Inker. “Removing race from GFR estimates: balancing potential benefits and unintended consequences.” Kidney Int 100, no. 1 (July 2021): 11–13. https://doi.org/10.1016/j.kint.2021.02.017.
Mounzer, Karam, Laurence Brunet, Christina M. Wyatt, Jennifer S. Fusco, Vani Vannappagari, Allan R. Tenorio, Mark S. Shaefer, Leigh Ragone, Ricky K. Hsu, and Gregory P. Fusco. “To dose-adjust or not to dose-adjust: lamivudine dose in kidney impairment.” Aids 35, no. 8 (July 1, 2021): 1201–8. https://doi.org/10.1097/QAD.0000000000002871.
Wudil, Usman J., Muktar H. Aliyu, Heather L. Prigmore, Donna J. Ingles, Aima A. Ahonkhai, Baba M. Musa, Hamza Muhammad, et al. “Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria.” Kidney Int 100, no. 1 (July 2021): 146–54. https://doi.org/10.1016/j.kint.2021.03.038.
Nickolas, Thomas L., Jonathan Barasch, Kenneth K. Mugwanya, Andrea D. Branch, Renee Heffron, Valentine Wanga, Nelly R. Mugo, et al. “Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis.” Aids 35, no. 7 (June 1, 2021): 1147–49. https://doi.org/10.1097/QAD.0000000000002865.
Hsu, R., L. Brunet, J. Fusco, A. Beyer, G. Prajapati, C. Wyatt, M. Wohlfeiler, and G. Fusco. “Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.” Hiv Med 22, no. 5 (May 2021): 325–33. https://doi.org/10.1111/hiv.13019.
Inker, Lesley A., Sara J. Couture, Hocine Tighiouart, Alison G. Abraham, Gerald J. Beck, Harold I. Feldman, Tom Greene, et al. “A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population.” Am J Kidney Dis 77, no. 5 (May 2021): 673-683.e1. https://doi.org/10.1053/j.ajkd.2020.11.005.
Ronco, Pierre, Brad H. Rovin, and Brad H. Entire Editorial and Management Team. “Looking back and moving forward.” Kidney Int 99, no. 4 (April 2021): 787–90. https://doi.org/10.1016/j.kint.2021.02.001.
Hughes, Kelly, Jerry Chang, Hannah Stadtler, Christina Wyatt, Mary Klotman, and Maria Blasi. “HIV-1 infection of the kidney: mechanisms and implications.” Aids 35, no. 3 (March 1, 2021): 359–67. https://doi.org/10.1097/QAD.0000000000002753.
Ronco, Pierre, Brad Rovin, Masaomi Nangaku, Christina Wyatt, Vivek Jha, and Vivek Associate Editors, for the Entire Editorial Team. “Milestones in nephrology and welcoming the future: the 61st anniversary of the International Society of Nephrology.” Kidney Int 99, no. 1 (January 2021): 2–4. https://doi.org/10.1016/j.kint.2020.10.020.
Edmonston, Daniel L., Matthew T. Roe, Geoffrey Block, Paul T. Conway, Laura M. Dember, Peter M. DiBattiste, Tom Greene, et al. “Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.” Am J Kidney Dis 76, no. 6 (December 2020): 842–50. https://doi.org/10.1053/j.ajkd.2020.05.026.